Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice

Daniel J J Carr, Linda L. Brockunier, Mace Scott, Jerome R. Bagley, Charles P France

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Mirfentanil [N-(2-pyrazinyl)-N-(1-phenethyl-4-piperidinyl)-2-furamide] was studied for its antinociceptive and immunomodulatory effects in mice. Mirfentanil (1.0-32.0 mg/kg) increased tail-flick latency to a thermal stimulus and this effect was antagonized (94 ± 2%) by naltrexone (10.0 mg/kg). Unlike naltrexone, the delta opioid selective antagonist naltrindole (20.0 mg/kg) had no effect on mirfentanil-induced analgesia. In a dose-dependent fashion, the μ-selective antagonists β-funaltrexamine (1.0-40.0 mg/kg) and naloxonazine (1.0-35.0 mg/kg) blocked mirfentanil (10.0 mg/kg)-induced analgesia up to 75% of the maximum analgesic effect. Norbinaltorphimine (10.0 mg/kg) partially blocked (35%) the maximum analgesic effect following mirfentanil (10.0 mg/kg) administration. Single doses of mirfentanil (0.1-32.0 mg/kg) had no effect on splenic NK activity. However, preadministration of mirfentanil (1.0-10.0 mg/kg) blocked morphine-induced suppression of splenic NK activity. Collectively, the results suggest that mirfentanil is a novel opioid that induces antinociception predominately through μ opioid receptors but, unlike morphine or fentanyl, does not suppress splenic NK activity.

Original languageEnglish (US)
Pages (from-to)9-16
Number of pages8
JournalImmunopharmacology
Volume34
Issue number1
DOIs
StatePublished - Aug 1996
Externally publishedYes

Fingerprint

Morphine
Naltrexone
naltrindole
mirfentanil
Analgesia
Analgesics
Narcotic Antagonists
Opioid Receptors
Fentanyl
Opioid Analgesics
Tail
Hot Temperature

Keywords

  • Analgesia
  • Immunomodulation
  • Mirfentanil
  • Morphine
  • Natural killer activity
  • Opioid

ASJC Scopus subject areas

  • Pharmacology

Cite this

Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice. / Carr, Daniel J J; Brockunier, Linda L.; Scott, Mace; Bagley, Jerome R.; France, Charles P.

In: Immunopharmacology, Vol. 34, No. 1, 08.1996, p. 9-16.

Research output: Contribution to journalArticle

Carr, Daniel J J ; Brockunier, Linda L. ; Scott, Mace ; Bagley, Jerome R. ; France, Charles P. / Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice. In: Immunopharmacology. 1996 ; Vol. 34, No. 1. pp. 9-16.
@article{e2926352e6c9469291e60474664f7958,
title = "Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice",
abstract = "Mirfentanil [N-(2-pyrazinyl)-N-(1-phenethyl-4-piperidinyl)-2-furamide] was studied for its antinociceptive and immunomodulatory effects in mice. Mirfentanil (1.0-32.0 mg/kg) increased tail-flick latency to a thermal stimulus and this effect was antagonized (94 ± 2{\%}) by naltrexone (10.0 mg/kg). Unlike naltrexone, the delta opioid selective antagonist naltrindole (20.0 mg/kg) had no effect on mirfentanil-induced analgesia. In a dose-dependent fashion, the μ-selective antagonists β-funaltrexamine (1.0-40.0 mg/kg) and naloxonazine (1.0-35.0 mg/kg) blocked mirfentanil (10.0 mg/kg)-induced analgesia up to 75{\%} of the maximum analgesic effect. Norbinaltorphimine (10.0 mg/kg) partially blocked (35{\%}) the maximum analgesic effect following mirfentanil (10.0 mg/kg) administration. Single doses of mirfentanil (0.1-32.0 mg/kg) had no effect on splenic NK activity. However, preadministration of mirfentanil (1.0-10.0 mg/kg) blocked morphine-induced suppression of splenic NK activity. Collectively, the results suggest that mirfentanil is a novel opioid that induces antinociception predominately through μ opioid receptors but, unlike morphine or fentanyl, does not suppress splenic NK activity.",
keywords = "Analgesia, Immunomodulation, Mirfentanil, Morphine, Natural killer activity, Opioid",
author = "Carr, {Daniel J J} and Brockunier, {Linda L.} and Mace Scott and Bagley, {Jerome R.} and France, {Charles P}",
year = "1996",
month = "8",
doi = "10.1016/0162-3109(95)00051-8",
language = "English (US)",
volume = "34",
pages = "9--16",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Mirfentanil antagonizes morphine-induced suppression of splenic NK activity in mice

AU - Carr, Daniel J J

AU - Brockunier, Linda L.

AU - Scott, Mace

AU - Bagley, Jerome R.

AU - France, Charles P

PY - 1996/8

Y1 - 1996/8

N2 - Mirfentanil [N-(2-pyrazinyl)-N-(1-phenethyl-4-piperidinyl)-2-furamide] was studied for its antinociceptive and immunomodulatory effects in mice. Mirfentanil (1.0-32.0 mg/kg) increased tail-flick latency to a thermal stimulus and this effect was antagonized (94 ± 2%) by naltrexone (10.0 mg/kg). Unlike naltrexone, the delta opioid selective antagonist naltrindole (20.0 mg/kg) had no effect on mirfentanil-induced analgesia. In a dose-dependent fashion, the μ-selective antagonists β-funaltrexamine (1.0-40.0 mg/kg) and naloxonazine (1.0-35.0 mg/kg) blocked mirfentanil (10.0 mg/kg)-induced analgesia up to 75% of the maximum analgesic effect. Norbinaltorphimine (10.0 mg/kg) partially blocked (35%) the maximum analgesic effect following mirfentanil (10.0 mg/kg) administration. Single doses of mirfentanil (0.1-32.0 mg/kg) had no effect on splenic NK activity. However, preadministration of mirfentanil (1.0-10.0 mg/kg) blocked morphine-induced suppression of splenic NK activity. Collectively, the results suggest that mirfentanil is a novel opioid that induces antinociception predominately through μ opioid receptors but, unlike morphine or fentanyl, does not suppress splenic NK activity.

AB - Mirfentanil [N-(2-pyrazinyl)-N-(1-phenethyl-4-piperidinyl)-2-furamide] was studied for its antinociceptive and immunomodulatory effects in mice. Mirfentanil (1.0-32.0 mg/kg) increased tail-flick latency to a thermal stimulus and this effect was antagonized (94 ± 2%) by naltrexone (10.0 mg/kg). Unlike naltrexone, the delta opioid selective antagonist naltrindole (20.0 mg/kg) had no effect on mirfentanil-induced analgesia. In a dose-dependent fashion, the μ-selective antagonists β-funaltrexamine (1.0-40.0 mg/kg) and naloxonazine (1.0-35.0 mg/kg) blocked mirfentanil (10.0 mg/kg)-induced analgesia up to 75% of the maximum analgesic effect. Norbinaltorphimine (10.0 mg/kg) partially blocked (35%) the maximum analgesic effect following mirfentanil (10.0 mg/kg) administration. Single doses of mirfentanil (0.1-32.0 mg/kg) had no effect on splenic NK activity. However, preadministration of mirfentanil (1.0-10.0 mg/kg) blocked morphine-induced suppression of splenic NK activity. Collectively, the results suggest that mirfentanil is a novel opioid that induces antinociception predominately through μ opioid receptors but, unlike morphine or fentanyl, does not suppress splenic NK activity.

KW - Analgesia

KW - Immunomodulation

KW - Mirfentanil

KW - Morphine

KW - Natural killer activity

KW - Opioid

UR - http://www.scopus.com/inward/record.url?scp=0030220817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030220817&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(95)00051-8

DO - 10.1016/0162-3109(95)00051-8

M3 - Article

C2 - 8880221

AN - SCOPUS:0030220817

VL - 34

SP - 9

EP - 16

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 1

ER -